SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-24-006774
Filing Date
2024-11-14
Accepted
2024-11-14 18:01:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 d11530244_13g-a.htm SC 13G/A 176540
  Complete submission text file 0000919574-24-006774.txt   178261
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91228 | Film No.: 241464867
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2828 N HARWOOD STREET SUITE 1220 DALLAS TX 75201
Business Address 2828 N HARWOOD STREET SUITE 1220 DALLAS TX 75201 214-550-1822
Avidity Partners Management LP (Filed by) CIK: 0001791827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A